Health Condition 1: K808- Other cholelithiasis
Conditions
Interventions
Intervention1: i/v dexamethasone: Patients of this group will receive Dexamethasone 8mg in 2ml and Normal Saline 2 ml I/V just before induction of anesthesia.
Control Intervention1: i/v haloperidol: P
Sponsors
Sharda Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients scheduled for elective laproscopic Cholecystectomy under General Anaesthesia. 2. ASA class 1 and 2. 3. Age 18-60 years. 4. Patients having at least two of following risk factors of PONV i.e ( Female gender , Non smoker , Prior history of PONV or motion sickness , being expected to receive opioid analgesia.)
Exclusion criteria
Exclusion criteria: 1.Patient receiving steroids, analgesics, antiemetic, sedatives and antipsychotics 2.Patient with past history of chronic pain. 3.Patient having history of endocrine, cardiovascular, renal or CNS disease 4.Patient having GI, Hepatic, renal disease. 5.Patient allergic to study drugs. 6.BMI more then 30.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effects of dexamethasone and haloperidol vs dexamethasone and amisulpride in comparison of control group on the incidence of post operative nausea vomiting in patient of laproscopic cholecystectomy under GA. Timepoint: 24 Hrs. | — |
Secondary
| Measure | Time frame |
|---|---|
| a)To compare the PONV free period and requirement of rescue antiemetic in three groups b)To compare the sedation score and pain score in three groups . Timepoint: 24 hrs. | — |
Countries
India
Contacts
Public ContactDR MAHENDERA KUMAR
School of Medical Sciences and Research
Outcome results
None listed